drugset / Trial / NCT06382155
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).
Timeline
- Start
- 2024-10-21
- Primary completion
- 2026-06
- Completion
- 2036-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Somatropin | Protein / enzyme biologic | — | — |
| Subject | Vosoritide | Peptide | — | — |